For example, it was reported that transfection with antisense XPA RNA could sensitize human lung adenocarcinoma cells to cisplatin [31], whereas, knocking down XPA did not increase cisplatin sensitivity in prostate cancer cell line, although down-regulation of XPA did inhibit cisplatin intrastrand crosslinks repair [42]. Here, XPA is linked to prostate cancer.